✦ LIBER ✦

PDB30 A MODELLED COST-EFFECTIVENESS ANALYSIS OF SWITCHING PATIENTS WITH POORLY CONTROLLED TYPE 2 DIABETES TO INSULIN DETEMIR FROM ORAL ANTIDIABETICS OR NPH IN THE AUSTRIAN SETTING; DATA FROM THE PREDICTIVE STUDY

✍ Scribed by L Stechemesser; R Weitgasser; M Hofmann; M Aagren; R Mihaljev

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB20 COST EFFECTIVENESS ANALYSIS OF SWI

✍ T Doležal; Z Písaríková; K Rychna; M Honka; D Bartášková 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

PDB24 COST EFFECTIVENESS ANALYSIS OF SWI

✍ E Suchankova; T Doležal; Z Pisarikova; K Rychna; D Bartaskova 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

PDB33 EVALUATING THE COST-EFFECTIVENESS

✍ L. Yang; A.L. Lay; J.H. Chang 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

Cost-Effectiveness of Switching Patients

✍ Li Yang; Torsten Christensen; Fengyu Sun; Jinghua Chang 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 288 KB

CE1 COST-EFFECTIVENESS OF SWITCHING PATI

✍ L Yang; T Christensen; J White; F Sun 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Transferring to insulin detemir from NPH

✍ A. Dornhorst; H.-J. Lüddeke; C. Koenen; M. Meriläinen; A. King; A. Robinson; S. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB